However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button. Objectives: Intravenous ketamine (IVK) and intranasal esketamine (ESK) are increasingly used in ...

The nasal spray is now undergoing phase three ... In the UK, doctors have been trialling ketamine to treat depression since 2011. Dr Rupert McShane, who has led a trial in Oxford, says ketamine ...

Meanwhile, the nasal spray form of ketamine ... study of open-label IV ketamine for refractory depression, Journal of Affective Disorders (2023). DOI: 10.1016/j.jad.2023.12.033 ...

It’s a significant finding because, to date, most studies of ketamine in depression have relied on either intravenous or intranasal administration, the latter resulting in the approval of J&J ...

BUFFALO, N.Y. — University at Buffalo neuroscientists have identified the binding site of low-dose ketamine, providing critical insight into how the medication, often described as a wonder drug, ...

WHILE KETAMINE OFTEN comes up in conversations about psychedelic medicine, technically it’s part of a class of drugs called ...

“One form of ketamine, an intranasal form ... How Can I Help a Loved One with Depression?

A watershed moment came in March when the U.S. Food and Drug Administration (FDA) approved Spravato, or esketamine, a ketamine nasal spray for adults with treatment-resistant major depression.

Although the FDA has approved ketamine for use as an anesthetic, infusion therapy hasn't been approved to treat chronic pain, depression, or other conditions.

Is ketamine a breakthrough ... a variation that has been approved for severe depression. Marketed as Spravato, it’s a nasal spray. While it’s been available for three years, it’s not ...

S-ketamine, also known as esketamine (Spravato), is an FDA-approved nasal spray for treatment-resistant depression and major depressive disorder with suicidal ideation or behavior. Esketamine ...